Evidence map›Paper›PMID 31183566›Full record

ArticleMikrochimica acta2019

Simultaneous amperometric immunosensing of the metastasis-related biomarkers IL-13Rα2 and CDH-17 by using grafted screen-printed electrodes and a composite prepared from quantum dots and carbon nanotubes for signal amplification.

Verónica Serafín, Alejandro Valverde, María Garranzo-Asensio, Rodrigo Barderas, Susana Campuzano, Paloma Yáñez-Sedeño, José M Pingarrón

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Verónica SerafínDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040, Madrid, Spain.
Alejandro ValverdeDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040, Madrid, Spain.
María Garranzo-AsensioUFIEC, Instituto de Salud Carlos III, 28220, Majadahonda, Madrid, Spain.
Rodrigo BarderasUFIEC, Instituto de Salud Carlos III, 28220, Majadahonda, Madrid, Spain.
Susana CampuzanoDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040, Madrid, Spain. susanacr@quim.ucm.es.
Paloma Yáñez-SedeñoDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040, Madrid, Spain. yseo@quim.ucm.es.ORCID 0000-0002-1232-2723
José M PingarrónDepartamento de Química Analítica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040, Madrid, Spain.
Universidad Complutense de Madrid · ESInstituto de Salud Carlos III · ES

Funding

Comunidad de Madrid P2018/NMT-4349Ministerio de Economía, Industria y Competitividad, Gobierno de España CTQ2015- 64402-C2-1-RMinisterio de Economía, Industria y Competitividad, Gobierno de España CTQ2015-70023-R
6 · The paper itself

Abstract

This paper describes a dual electrochemical immunoassay for the simultaneous determination of IL-13Rα2 and CDH-17, two biomarkers of emerging relevance in metastatic processes. The sandwich assay uses a screen-printed dual carbon electrode that was electrochemically grafted with p-aminobenzoic acid to allow the covalent immobilization of capture antibodies. A hybrid composed of graphene quantum dots (GQDs) and multiwalled carbon nanotubes (MWCNTs) act as nanocarriers for the detection antibodies and horseradish peroxidase. The use of this hybrid material considerably improves the assay (in comparison to the use of MWCNTs) due to the peroxidase mimicking activity of the GQDs. The method works at a low working potential (0.20 V vs. Ag pseudo-reference electrode) and thus is not readily interfered by unknown electroactive species. The dual immunoassay allows for the selective determination of both biomarkers with LOD values of 1.4 (IL-13sRα2) and 0.03 ng mL

Indexed as

Biomarkers, TumorBiosensing TechniquesCadherinsCell Line, TumorElectrochemical TechniquesElectrodesGraphiteHumansImmobilized ProteinsImmunoassayInterleukin-13 Receptor alpha2 SubunitLimit of DetectionNanotubes, CarbonNeoplasm MetastasisQuantum DotsSensitivity and SpecificityBiomarkers, TumorCadherinsCDH17 protein, humanGraphiteImmobilized ProteinsInterleukin-13 Receptor alpha2 SubunitNanotubes, CarbonColorectal cancerDual immunosensorElectrochemical immunosensorGraphene quantum dotsMetastasis-related biomarkersParaffin-embedded tissuesPeroxidase mimicSignal amplification

Identifiers

PMID31183566
OpenAlexW2952137789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.